Implications of alterations in trace element levels in brain in Parkinson's disease and other neurological disorders affecting the basal ganglia.
Dexter
D T
DT
Parkinson's Disease Society Experimental Research Laboratories, King's College London, United Kingdom.
Sian
J
J
Jenner
P
P
Marsden
C D
CD
D001479:Basal Ganglia / Q000473:pathology; D001480:Basal Ganglia Diseases / Q000473:pathology*; D003300:Copper / Q000032:analysis; D005293:Ferritins / Q000032:analysis; D005609:Free Radicals; D006801:Humans; D007501:Iron / Q000032:analysis; D009434:Neural Pathways / Q000473:pathology; D009474:Neurons / Q000473:pathology; D010300:Parkinson Disease / Q000473:pathology*; D013378:Substantia Nigra / Q000473:pathology*; D014131:Trace Elements / Q000032:analysis*; D015032:Zinc / Q000032:analysis
D005609:Free Radicals; D014131:Trace Elements; D003300:Copper; D005293:Ferritins; D007501:Iron; D015032:Zinc